CAJ | 학술논문

目的：评价临床路径在三级医院支气管肺癌化疗患者中的应用效果。方法采用回顾性调查方法，通过同期对照研究，对呼吸内科实施和未实施支气管肺癌化疗临床路径的60例患者（20例小细胞肺癌和40例非小细胞肺癌）进行统计，对平均住院日、平均住院费用、药品费用、药占比和检查费用进行比较分析。结果实施临床路径后小细胞肺癌及非小细胞肺癌化疗住院时间分别缩短0．72天和0．7天，差异有统计学意义（P＜0．05）、检查费用降低（P＜0．05），小细胞肺癌化疗平均住院费用、药品费用及药占比显著减少（P＜0．05）。结论通过实施临床路径，可以缩短支气管肺癌化疗的住院时间，降低检查费用，减少部分患者的平均住院费用和药品费用，减轻患者经济负担。
목적：평개림상로경재삼급의원지기관폐암화료환자중적응용효과。방법채용회고성조사방법，통과동기대조연구，대호흡내과실시화미실시지기관폐암화료림상로경적60례환자（20례소세포폐암화40례비소세포폐암）진행통계，대평균주원일、평균주원비용、약품비용、약점비화검사비용진행비교분석。결과실시림상로경후소세포폐암급비소세포폐암화료주원시간분별축단0．72천화0．7천，차이유통계학의의（P＜0．05）、검사비용강저（P＜0．05），소세포폐암화료평균주원비용、약품비용급약점비현저감소（P＜0．05）。결론통과실시림상로경，가이축단지기관폐암화료적주원시간，강저검사비용，감소부분환자적평균주원비용화약품비용，감경환자경제부담。
Objiective To evaluate the effect of application of clinical pathway in bronchogenic cancer chemotherapy in level-three hospital.Methods A retrospective analysis was performed on 60 bronchogenic canc-er patients received chemotherapy, which contained 20 small cell lung cancer patients and 40 non-small cell lung cancer patients.The average costs of hospitalization days, hospitalization expenses, costs of drugs, drug proportion and auxiliary examinations comparative were analyzed.Results The hospitalization time was shortened 0.72d and 0.7d in both small cell lung cancer and non-small cell lung cancer clinical pathway sub-group respectively com-pared with control sub-group ( P<0 .05 ) .The auxiliary examinations costs decreased in both clinical subgroups significantly (P<0.05).The average hospitalization expenses, drugs expenses and drugs proportion was signifi-cantly reduced in small cell lung cancer chemotherapy subgroup (P<0.05).Conclusion Clinical pathway can shorten the time of hospitalization and examination costs of lung cancer chemotherapy, reduce the average hospitali-zation expenses and drug expenses of partial patients, so as to reduce the economic burden of these patients.